Latest news
Greenstone Biosciences Receives NIH Grant To Develop Cardiac Fibrosis Treatments For Duchenne Muscular Dystrophy - Pulse 2.0Pulse 2.0 · Fri, 07 Aug 2026 12:48:12 GMTGreenstone Biosciences Receives NIH R61 Grant to Advance Cardiac Fibrosis Therapeutics for Duchenne Muscular Dystrophy - Business WireBusiness Wire · Thu, 06 Aug 2026 23:35:00 GMTThe Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformantBioInformant · Sun, 02 Aug 2026 07:00:00 GMT